Ad
related to: biogen's aduhelm- About Leqembi
Learn more about the treatment
option & how it works.
- Getting Started
Find treatment tips to get started
with Leqembi.
- Support & Resources
View patient support info and
downoadable resources on site.
- Leqembi Companion
Your online partner designed to
support you during treatment.
- Leqembi Care Partner
Explore tips for supporting
patients who are taking Leqembi.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Leqembi
Search results
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
We read through the 45-page congressional investigation into Biogen's Alzheimer's drug. Here are the...
INSIDER via Yahoo News· 1 year agoThe Biogen headquarters in Cambridge, Mass.AP Photo/Steven Senne A Congressional investigation into...
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Motley Fool· 1 year agoIn June 2021, shares of Biogen (NASDAQ: BIIB) soared to more than $400 after the Food and Drug...
Biogen (BIIB) to Report Q2 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 11 months agoBiogen's sales in the second quarter are likely to have been hurt by lower sales of its multiple...
Congressional report: U.S. FDA broke own protocols in approving Biogen Alzheimer's drug
Reuters via Yahoo News· 1 year agoThe U.S. Food and Drug Administration failed to adhere to its own guidance and internal practices...
1 Reason to Buy Biogen Stock, and 1 Reason to Sell
Motley Fool· 1 year agoBiogen (NASDAQ: BIIB) has been one of the more notable names in the biotech industry in the past four years -- and not always for the best of reasons....
Biogen (BIIB) to Report Q3 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 7 months agoBiogen's (BIIB) sales in the third quarter are likely to have been hurt by lower sales of its...
Biogen's (BIIB) Partner Eisai Files MAA for Lecanemab in Europe
Zacks via Yahoo Finance· 1 year agoBiogen's (BIIB) partner Eisai files a marketing authorization application to the European Medicines...
Biogen's Alzheimer's Drug Success Pops Stocks Across the Industry
Motley Fool· 2 years agoFor more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter....
Biogen (BIIB) Up 29% in a Year Despite Multiple Challenges
Zacks via Yahoo Finance· 1 year agoMost of Biogen's (BIIB) key drugs are facing declining sales. Despite these challenges, potential...
Ad
related to: biogen's aduhelm